Link Medicine, a drug developer for brain diseases previously backed by two strategic investors, has raised $20m in its fourth round of funding.
Link Medicine, a US-based drug developer for brain diseases previously backed by two strategic investors, has raised $20m in its fourth round of funding.
Two years ago, Link raised a $40m series C round from venture capital firms Clarus Ventures and SV Life Sciences and its previous investors have included the corporate venturing divisions Endurance Investments and Biogen Idec New Ventures.
